Animal model

Short description

An animal model is a non-human animal species used in biomedical research because it can mimic aspects of a biological process or disease that occur in humans.

New combination therapy offers chance of healing hepatitis B

Around 260 million people, more than three percent of the global population, are chronically infected with the hepatitis B virus (HBV); in the long term, this often leads to complications such as

Ludwig-Maximilians-Universität München

Reduction and elimination of HIV reservoirs

The development of potent antiretroviral treatment (ART) strategies has significantly changed the face of the HIV/AIDS pandemic from a lethal disease to a chronic livable condition for infected individuals with access to care. However, in spite of ground-breaking advances in anti-HIV treatment, cure ...

PANTIPA: Monoclonal antibodies targeting Pseudomonas aeruginosa

Pseudomonas aeruginosa is a multidrug-resistant bacterium that can cause life-threatening infections, such as sepsis and pneumonia. One of the key weapons used by this bacterium is the type III

Measles virus as vector for a COVID-19 vaccine.

As part of the research activities within the German Center for Infection Research (DZIF), scientists of the Paul-Ehrlich-Institut studied specific vaccine candidates against COVID-19. They are based

Alina Renz, Lina Widerspick und Andreas Dräger

SARS-CoV-2: Bioinformaticians discover a new weakness of the virus

The search for effective antiviral agents against the new coronavirus is in full swing. Using a novel approach, Tübingen bioinformaticians have now discovered a weakness in the virus that could be

04 Nov 2020

Webinar

Federal Institute for Drugs and Medical Devices (BfArM)
Weekly webinar
Germany

internal

CPT Pharmacometrics Syst Pharmacol

Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials

Autoren

Madelain V et al.

More about “Animal model”

New combination therapy offers chance of healing hepatitis B

Reduction and elimination of HIV reservoirs

PANTIPA: Monoclonal antibodies targeting Pseudomonas aeruginosa

Measles virus as vector for a COVID-19 vaccine.

SARS-CoV-2: Bioinformaticians discover a new weakness of the virus

Hit-to-Lead & Lead Optimization of Small Molecules and Natural Products

A vaccine candidate against The Epstein-Barr virus

New active agent against hospital pathogens

Small-molecule inhibitors of Staphylococcus aureus alpha-toxin for severe lung infections

Modeling favipiravir antiviral efficacy against emerging viruses: from animal studies to clinical trials